Home - Products - Others - Other Targets - Cholecystokinin Octapeptide (2-8) (desulfated)

Cholecystokinin Octapeptide (2-8) (desulfated)

CAS No. 47910-79-2

Cholecystokinin Octapeptide (2-8) (desulfated)( ——— )

Catalog No. M41025 CAS No. 47910-79-2

CCK (27-33) is the C-terminal heptapeptide of cholecystokinin (CCK).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cholecystokinin Octapeptide (2-8) (desulfated)
  • Note
    Research use only, not for human use.
  • Brief Description
    CCK (27-33) is the C-terminal heptapeptide of cholecystokinin (CCK).
  • Description
    CCK (27-33) is the C-terminal heptapeptide of cholecystokinin (CCK).
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    47910-79-2
  • Formula Weight
    948.14
  • Molecular Formula
    C45H57N9O10S2
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Schiller PW, et al. Unsulfated C-terminal 7-peptide of cholecystokinin: a new ligand of the opiate receptor. Biochem Biophys Res Commun. 1978 Dec 29;85(4):1332-8. ?
molnova catalog
related products
  • Nortrachelogenin-8'-...

    Nortrachelogenin-8'-O-beta-glucoside is a lignan with a diarylhydroxybutyrolactone skeleton which isolated from the leaves and stems of Trachelospermum jasminoides (Lindl.) Lem.

  • BBD

    BBD (Benzylamino-NBD) is a biochemical and chromogenic reagent.

  • Miriplatin hydrate

    Miriplatin hydrate (SM-11355 (hydrate)) (MPT) is a novel platinum complex used in TACE that shows promise for the treatment of hepatocellular carcinoma (HCC).